Data from a phase 2 trial of Roche's oral BTK inhibitor fenebrutinib have shown "near-complete suppression" of disease activity and disability progression in relapsing multiple sclerosis (MS). The ...
Global sustainable funds faced net outflows of approximately USD 55 billion in Q3 2025, a sharp reversal from the USD 5.8 billion inflows in the previous quarter. This shift was driven primarily by ...
Morgan Stanley operates as a global financial services company. The firm provides investment banking products and services to its clients and customers including corporations, governments, financial ...